share_log

羚锐制药董事会对独立董事2023年度独立性情况评估的专项意见

Special opinion of the board of directors of Lingrui Pharmaceutical on the 2023 independence assessment of independent directors

Sensex a share ·  Apr 25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more